Drugs / AIPO4
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02777411 | Dec 2014 → Jan 2016 | enterovirus infectious disease | Enimmune Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIPO4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02777411 ↗ |